What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001584258
Total reported value
$1.1B
$1.1B
10 檔
2.4%
At the close of Q3 2024, Dumac, Inc. disclosed equity holdings valued at approximately $1.1B, spread across 10 reported holdings.
In Q3 2024, Dumac, Inc. adopted a defensive or profit-taking posture, trimming 0 positions and completely liquidating 1 holdings to manage risk exposure.
In terms of portfolio concentration, the top 5 core holdings (including RIGL, INDA, MMYT) accounted for 2.4% of total reported equity market value during Q3 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RIGL | Rigel Pharmaceuticals, Inc. | Stock-Other | 37.33% | — | — | |
| 2 | INDA | Ishares Msci India ETF | ETF-Other | 20.14% | -0.24% | — | |
| 3 | MMYT | MakeMyTrip Limited | Stock-Other | 12.18% | -0.05% | — | |
| 4 | ✓ | Despegar.com CORP | Stock-Other | 8.77% | — | — | |
| 5 | KSPI | Jsc Kaspi.kz Adr | Stock-Other | 8.72% | -0.03% | — | |
| 6 | ZTO | Zto Express Cayman Inc-adr | Stock-Other | 7.78% | -0.30% | EXIT | |
| 7 | ARCO | Arcos Dorados Holdings Inc. | Stock-Other | 1.72% | -0.02% | — | |
| 8 | SGMT | Sagimet Biosciences Inc-a | Stock-Other | 1.70% | — | — | |
| 9 | IHS | IHS Holding Limited | Stock-Other | 1.09% | — | — | |
| 10 | ✓ | Rigel Resource Acq CORP | Stock-Other | 0.57% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ZTO | Zto Express Cayman Inc-adr | +1.4% | — | Unchanged |
| 2 | MMYT | MakeMyTrip Limited | +1.3% | — | Unchanged |
| 3 | INDA | Ishares Msci India ETF | +1.2% | — | Unchanged |
| 4 | RIGL | Rigel Pharmaceuticals, Inc. | +1.1% | — | Unchanged |
| 5 | ✓ | Rigel Resource Acq CORP | +0.2% | — | Unchanged |
| 6 | ARCO | Arcos Dorados Holdings Inc. | 0% | — | Unchanged |
| 7 | IHS | IHS Holding Limited | -0.1% | — | Unchanged |
| 8 | SGMT | Sagimet Biosciences Inc-a | -0.4% | — | Unchanged |
| 9 | ✓ | Despegar.com CORP | -0.4% | — | Unchanged |
| 10 | KSPI | Jsc Kaspi.kz Adr | -1.7% | — | Unchanged |
| 11 | ✓ | Lanzatech Global Inc | -2.6% | EXIT | Sold out |
According to official SEC Form 13F filings, Dumac, Inc. reported a total U.S. public equity portfolio value of $1.1B across 10 disclosed positions in Q3 2024.
During Q3 2024, Dumac, Inc.'s top holdings by market value included RIGL (37.3%)、INDA (20.1%)、MMYT (12.2%). The largest single position, RIGL, represented 37.3% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top Position Liquidated / Trimmed
LANZATECH GLOBAL INC
前期市值: $811.2K
In Q3 2024, Dumac, Inc. made 1 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.